 |
 |

Sjögren-Larsson Syndrome and Crystalline Maculopathy Associated With a Novel Mutation
Erold Jean-François, MD;
Jessica Y. Low, BS;
Christine R. Gonzales, MD;
David Sarraf, MD
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Sjögren-Larsson syndrome is an autosomal recessive neurocutaneous disorder characterized by congenital ichthyosis, spasticity, and mental retardation.1-3 Ichthyosis is commonly the earliest sign and is usually present at birth.1 Spastic diplegia or tetraplegia and varying degrees of mental retardation usually emerge in the first 2 years of life.1-2 Additional findings include short stature, seizure disorder, speech defects, and enamel hypoplasia.
Crystalline maculopathy has been reported to occur in up to 100% of patients affected with this rare disorder.2 To our knowledge, this case report is the first to describe the optical coherence tomographic findings of the crystalline maculopathy. Moreover, our case was associated with a novel mutation in the fatty aldehyde dehydrogenase enzyme gene not previously reported in the literature to our knowledge.
Report of a Case
Institutional review board approval was obtained from the Charles R. Drew University of Medicine . . . [Full Text of this Article] Comment
AUTHOR INFORMATION
|